Scientists are discovering that the bacteria living inside the human gut may have far more influence on health than anyone once imagined.
These microscopic organisms help digest food, produce nutrients, support the immune system, and may even affect body weight, metabolism, and blood sugar control.
A new study from the University of Gothenburg now suggests that gut bacteria could play a major role in why some people see dramatic improvements in type 2 diabetes after weight-loss surgery.
The study was published in Nature Metabolism and followed patients who underwent bariatric surgery, one of the most effective treatments for severe obesity.
Bariatric surgery is often recommended for people who struggle with obesity and related diseases such as type 2 diabetes. The two most common procedures are gastric bypass and sleeve gastrectomy.
Both surgeries reduce the size of the stomach and help people eat less food. Many patients lose a large amount of weight afterward, and some experience major improvements in blood sugar levels. In some cases, diabetes symptoms improve so much that patients need fewer medications or no medication at all.
But doctors have long been puzzled by one important question: why do some patients improve far more than others?
Researchers behind the new study suspected that gut bacteria might help explain these differences.
Inside the digestive system live trillions of bacteria and other microorganisms, collectively known as the gut microbiota. Scientists increasingly believe these microbes interact closely with metabolism and may influence obesity and diabetes in ways researchers are only beginning to understand.
To investigate this, researchers analyzed the gut microbiota of patients before and after bariatric surgery.
The team used advanced genetic technology to study microbial genes in great detail. This approach allowed scientists to examine not just the types of bacteria present, but also what those bacteria were doing inside the gut.
Patients were then followed for up to five years after surgery while researchers tracked changes in blood sugar control and metabolic health.
The study found that patients with the greatest improvements in diabetes also experienced the largest positive changes in their gut microbiome.
Their gut bacteria became more diverse and showed greater microbial gene richness. In general, greater diversity in gut bacteria is considered a sign of a healthier gut ecosystem.
Researchers also found increased activity in bacterial fermentation processes. One important result was higher production of butyric acid, a substance produced when gut bacteria break down dietary fiber.
Butyric acid has attracted growing scientific interest because it may help reduce inflammation, strengthen the gut lining, and improve insulin sensitivity.
The findings suggest that changes in gut bacteria may actively contribute to improved blood sugar control after surgery rather than simply being a side effect of weight loss.
Researchers emphasized that the improvements could not be explained by weight loss alone.
This is important because bariatric surgery has traditionally been viewed mainly as a way to reduce food intake and body weight. The new research suggests that surgery may also work by dramatically reshaping the gut ecosystem.
The study also revealed differences between the two surgical procedures.
Gastric bypass tended to create more predictable and consistent changes in gut bacteria among patients. Sleeve gastrectomy produced more individualized changes, meaning different patients experienced more varied microbiome responses.
Scientists say this could partly explain why patient outcomes after surgery often differ.
The researchers believe these findings may eventually lead to more personalized treatments for obesity and diabetes.
In the future, doctors may be able to study a patient’s gut microbiome before surgery to predict how likely they are to experience diabetes remission afterward.
Researchers also believe future treatments might directly target gut bacteria through diet, probiotics, or other microbiome-based therapies.
Professor Fredrik Bäckhed from the University of Gothenburg explained that the study suggests the microbiome is not simply observing what happens after surgery. Instead, it may actively help drive metabolic improvements.
This raises the exciting possibility that some of the benefits of bariatric surgery could someday be recreated without surgery itself.
The study reflects a much larger shift happening in medical research today. Scientists increasingly recognize that gut bacteria may influence many chronic diseases, including obesity, diabetes, heart disease, inflammatory bowel disease, and even mental health conditions.
However, researchers also caution that the field is still developing.
Although the study found strong links between gut bacteria and diabetes improvement, it does not fully prove cause and effect. Scientists still need to determine exactly which bacterial species and microbial functions are most important.
The study’s strengths include its long-term follow-up period and the use of highly detailed metagenomic analysis. These advanced techniques allowed researchers to uncover patterns that older studies may have missed.
Still, larger studies involving more diverse populations will be needed before microbiome-based therapies become common medical practice.
Looking at the findings overall, the research provides another powerful reminder that human health is deeply connected to the invisible microbial world living inside the body.
The study also suggests that future diabetes treatments may become much more personalized, focusing not only on body weight and medications but also on reshaping the gut ecosystem itself.
If you care about diabetes, please read studies about diabetes and vitamin B12, and the right diet for people with type 2 diabetes.
For more health information, please see recent studies about how to eat smart with diabetes, and turmeric and vitamin D: a duo for blood pressure control in diabetic patients.
Source: University of Gothenburg.
